Valuation: BOIRON

Market Cap 458M 531M 430M 392M 736M 50.77B 747M 5.04B 1.98B 25.43B 1.99B 1.95B 84.6B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 411M 476M 385M 351M 660M 45.47B 669M 4.51B 1.77B 22.78B 1.79B 1.75B 75.77B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.38%
Current month-4.01%
1 month-1.87%
3 months-5.40%
6 months-3.84%
Current year-13.20%
1 week 25.7
Extreme 25.7
26.7
1 month 25.7
Extreme 25.7
28
Current year 24.35
Extreme 24.35
30.95
1 year 20.9
Extreme 20.9
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%0.00%+25.24%-48.43% 531M
-0.46%-1.89%-11.01%-6.99% 13.24B
-0.16%-2.40%-32.52%-57.64% 4.98B
-0.81%-3.56%+2.32%-3.16% 4.91B
+0.29%+0.12%+7.12%-28.17% 4.2B
-0.03%-2.74%-18.37%+0.58% 3.59B
+0.20%-2.29%-5.07%+13.86% 3.4B
-1.06%-6.37%-8.56%-9.04% 3.35B
+1.19%+0.94%-12.60%-15.53% 2.49B
0.00%+10.60%+3.45%-10.45% 1.81B
Average -0.12%-0.52%-5.00%-16.50% 4.25B
Weighted average by Cap. -0.23%-1.33%-9.17%-13.59%

Financials

2024 2025
Net sales 488M 565M 457M 417M 783M 54B 794M 5.36B 2.1B 27.05B 2.12B 2.07B 89.99B 501M 580M 470M 428M 805M 55.5B 816M 5.51B 2.16B 27.8B 2.18B 2.13B 92.49B
Net income 11.34M 13.13M 10.63M 9.69M 18.21M 1.26B 18.47M 125M 48.85M 629M 49.3M 48.23M 2.09B 32.64M 37.81M 30.62M 27.89M 52.45M 3.62B 53.17M 359M 141M 1.81B 142M 139M 6.03B
Net Debt -49.74M -57.61M -46.66M -42.5M -79.91M -5.51B -81.02M -547M -214M -2.76B -216M -212M -9.18B -47.86M -55.43M -44.9M -40.89M -76.89M -5.3B -77.95M -526M -206M -2.66B -208M -204M -8.83B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-08-17 26.30 -0.38% 1,004
26-08-14 €26.40 -0.38% 2,710
26-08-13 €26.50 0.00% 713
26-08-12 €26.50 +1.53% 772
26-08-11 €26.10 -0.76% 21,624

Annual profits - Rate of surprise